According to Rock Health's analysis, startups raised $2.2 billion across 125 deals, making Q3 the lowest quarter by dollars raised since Q4 2019.
A review published in JAMA Network Open evaluated 41 RCTs of machine learning interventions. None of the studies fully followed CONSORT-AI standards, a set of guidelines developed for clinical trials evaluating medical interventions that include AI.
The UK-based wearable medical device company plans to use the funds to expand in Europe and North America.
During a discussion hosted by Frost & Sullivan, panelists examined how healthcare organizations should use digital tools to ensure care is easy to access.
The new allocation will help the company expand its insurance coverage, including Medicare and Medicaid, across the U.S.
Also, a new research centre at the University of Melbourne will use AI to advance breast cancer screening.
Also, Point Robotics from Taiwan has received a US FDA 510(k) clearance for its surgical robot system.
A J.D. Power study indicates telehealth is the preferred method among consumers for receiving certain types of medical care.
The startup's first product asks patients questions about their concerns and provides a summary with recommendations for follow-up to the physician.
Komodo Health appointed Lauren Stahl as vice president and head of sales, while Woebot Health and Cue Health hired chief commercial officers.
